In addition, we revealed that serum ADAM15 concentrations were significantly higher in CRC patients with the presence of distant metastasis (M1 subgroup) in comparison to the M0 subgroup, similar to the CEA and CRP levels. Here, CEACAM5 is linked to colorectal carcinoma.